CAS 56961-10-5

SARS-CoV-2-IN-13

CAS: 56961-10-5

SARS-CoV-2-IN-13

Pureza: ≥98%

Peso molecular: 327.12g/mol

Ref: 54-BUP08581

SARS-CoV-2-IN-13

CAS: 56961-10-5

SARS-CoV-2-IN-13, a stable niclosamide analogue, enhances oral bioavailability and inhibits SARS-CoV-2 (IC50: 0.057 μM).

Fórmula: C₁₃H₈Cl₂N₂O₄

Pureza: 98.54%

Cor e Forma: Solid

Peso molecular: 327.12

Ref: TM-T60919